Document is current
Any future updates will be listed below
-
Authors
Alves Pegoraro, Juliana
Guerder, Antoine
Similowski, Thomas
Salamitou, Philippe
Gonzalez-Bermejo, Jesus
Birmelé, Etienne
-
Funding
Funding for this research was provided by:
Association Nationale de la Recherche et de la Technologie
- License Information
-
More Information
Article History
Received: 30 June 2024
Accepted: 18 February 2025
First Online: 25 February 2025
Declarations
:
: The protocol was reviewed and approved (CEPRO 2018-021) by the Institutional Review Board of the French learned society for respiratory medicine - Société de Pneumologie de Langue Française. Patients provided written informed consent.
: Not applicable.
: JAP was employed by Srett during the development of the study and is employed by Löwenstein Medical Technology. PS is the founder and CEO of Srett. JAP, TS, PS, JG-B, and EB are inventors of the patent EP20315396.0, in which a respiration monitoring system combining breathing rate and signal amplitude measures is covered. All other authors declare that they do not have any competing interest.
